104 related articles for article (PubMed ID: 23676529)
1. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
2. Neurobiological and clinical effects of fNIRS-controlled rTMS in patients with panic disorder/agoraphobia during cognitive-behavioural therapy.
Deppermann S; Vennewald N; Diemer J; Sickinger S; Haeussinger FB; Dresler T; Notzon S; Laeger I; Arolt V; Ehlis AC; Fallgatter AJ; Zwanzger P
Neuroimage Clin; 2017; 16():668-677. PubMed ID: 29085773
[TBL] [Abstract][Full Text] [Related]
3. RANDOMIZED TRIAL OF D-CYCLOSERINE ENHANCEMENT OF COGNITIVE-BEHAVIORAL THERAPY FOR PANIC DISORDER.
Otto MW; Pollack MH; Dowd SM; Hofmann SG; Pearlson G; Szuhany KL; Gueorguieva R; Krystal JH; Simon NM; Tolin DF
Depress Anxiety; 2016 Aug; 33(8):737-45. PubMed ID: 27315514
[TBL] [Abstract][Full Text] [Related]
4. Usage and longitudinal effectiveness of a Web-based self-help cognitive behavioral therapy program for panic disorder.
Farvolden P; Denisoff E; Selby P; Bagby RM; Rudy L
J Med Internet Res; 2005 Mar; 7(1):e7. PubMed ID: 15829479
[TBL] [Abstract][Full Text] [Related]
5. Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial.
Goodyer I; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
BMJ; 2007 Jul; 335(7611):142. PubMed ID: 17556431
[TBL] [Abstract][Full Text] [Related]
6. Respiratory and cognitive mediators of treatment change in panic disorder: evidence for intervention specificity.
Meuret AE; Rosenfield D; Seidel A; Bhaskara L; Hofmann SG
J Consult Clin Psychol; 2010 Oct; 78(5):691-704. PubMed ID: 20873904
[TBL] [Abstract][Full Text] [Related]
7. The impact of an 8-day intensive treatment for adolescent panic disorder and agoraphobia on comorbid diagnoses.
Gallo KP; Chan PT; Buzzella BA; Whitton SW; Pincus DB
Behav Ther; 2012 Mar; 43(1):153-9. PubMed ID: 22304887
[TBL] [Abstract][Full Text] [Related]
8. Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale.
Furukawa TA; Katherine Shear M; Barlow DH; Gorman JM; Woods SW; Money R; Etschel E; Engel RR; Leucht S
Depress Anxiety; 2009; 26(10):922-9. PubMed ID: 19006198
[TBL] [Abstract][Full Text] [Related]
9. Neural mechanisms and predictors of SSRI and CBT treatment of anxiety: A randomized trial focused on emotion and cognitive processing.
Kinney KL; Burkhouse KL; Chang F; MacNamara A; Klumpp H; Phan KL
J Anxiety Disord; 2021 Aug; 82():102449. PubMed ID: 34274600
[TBL] [Abstract][Full Text] [Related]
10. Nucleus accumbens volume as a predictor of anxiety symptom improvement following CBT and SSRI treatment in two independent samples.
Burkhouse KL; Jagan Jimmy ; Defelice N; Klumpp H; Ajilore O; Hosseini B; Fitzgerald KD; Monk CS; Phan KL
Neuropsychopharmacology; 2020 Feb; 45(3):561-569. PubMed ID: 31756730
[TBL] [Abstract][Full Text] [Related]
11. Predictors and moderators of treatment dropout in cognitive-behavioral and psychodynamic therapies for panic disorder.
Keefe JR; Chambless DL; Barber JP; Milrod BL
Psychother Res; 2021 Apr; 31(4):432-442. PubMed ID: 32584211
[No Abstract] [Full Text] [Related]
12. Panic control treatment and its applications.
Hofmann SG; Spiegel DA
J Psychother Pract Res; 1999; 8(1):3-11. PubMed ID: 9888103
[TBL] [Abstract][Full Text] [Related]
13. Processes of therapeutic change: Results from the Cornell-Penn Study of Psychotherapies for Panic Disorder.
Barber JP; Milrod B; Gallop R; Solomonov N; Rudden MG; McCarthy KS; Chambless DL
J Couns Psychol; 2020 Mar; 67(2):222-231. PubMed ID: 32105128
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of change in cognitive behavioral therapy for panic disorder: the unique effects of self-efficacy and anxiety sensitivity.
Gallagher MW; Payne LA; White KS; Shear KM; Woods SW; Gorman JM; Barlow DH
Behav Res Ther; 2013 Nov; 51(11):767-77. PubMed ID: 24095901
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of effect of brief-intensive cognitive behavior therapy on symptoms severity in relation with catastrophic cognition in patients with panic disorder: a randomized controlled trial.
Piro RS; Taha PH
Curr Med Res Opin; 2024 Apr; 40(4):689-699. PubMed ID: 38465410
[TBL] [Abstract][Full Text] [Related]
16. The identification and psychological treatment of panic disorder in adolescents: a survey of CAMHS clinicians.
Baker HJ; Waite P
Child Adolesc Ment Health; 2020 Sep; 25(3):135-142. PubMed ID: 32516502
[TBL] [Abstract][Full Text] [Related]
17. Cognitive-behavioral therapy for panic disorder in patients being treated for alcohol dependence: Moderating effects of alcohol outcome expectancies.
Kushner MG; Sletten S; Donahue C; Thuras P; Maurer E; Schneider A; Frye B; Van Demark J
Addict Behav; 2009; 34(6-7):554-60. PubMed ID: 19349122
[TBL] [Abstract][Full Text] [Related]
18. Dismantling cognitive-behaviour therapy for panic disorder: a systematic review and component network meta-analysis.
Pompoli A; Furukawa TA; Efthimiou O; Imai H; Tajika A; Salanti G
Psychol Med; 2018 Sep; 48(12):1945-1953. PubMed ID: 29368665
[TBL] [Abstract][Full Text] [Related]
19. Antianxiety medications for the treatment of complex agoraphobia: pharmacological interventions for a behavioral condition.
Perna G; Daccò S; Menotti R; Caldirola D
Neuropsychiatr Dis Treat; 2011; 7():621-37. PubMed ID: 22090798
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cognitive insight in panic disorder: phenomenology and treatment effects in internet cognitive behavior therapy.
Halaj A; Strauss AY; Zlotnick E; Zalaznik D; Fradkin I; Andersson G; Ebert DD; Huppert JD
J Psychiatr Res; 2024 Apr; 172():164-170. PubMed ID: 38387117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
